| 000 | 01517 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513191101.0 | ||
| 264 | 0 | _c19990914 | |
| 008 | 199909s 0 0 eng d | ||
| 022 | _a0145-479X | ||
| 024 | 7 |
_a10.1023/a:1005455912711 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCatisti, R | |
| 245 | 0 | 0 |
_aPermeability transition pore closure promoted by quinine. _h[electronic resource] |
| 260 |
_bJournal of bioenergetics and biomembranes _cApr 1999 |
||
| 300 |
_a153-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntimycin A _xpharmacology |
| 650 | 0 | 4 |
_aCalcimycin _xpharmacology |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 |
_aCarbonyl Cyanide p-Trifluoromethoxyphenylhydrazone _xpharmacology |
| 650 | 0 | 4 |
_aIntracellular Membranes _xdrug effects |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aMembrane Potentials _xdrug effects |
| 650 | 0 | 4 |
_aMitochondria _xdrug effects |
| 650 | 0 | 4 |
_aMitochondria, Liver _xdrug effects |
| 650 | 0 | 4 |
_aMitochondrial Swelling _xdrug effects |
| 650 | 0 | 4 |
_aOnium Compounds _xpharmacology |
| 650 | 0 | 4 |
_aOrganophosphorus Compounds _xpharmacology |
| 650 | 0 | 4 | _aPermeability |
| 650 | 0 | 4 |
_aQuinine _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aThiocyanates _xpharmacology |
| 700 | 1 | _aVercesi, A E | |
| 773 | 0 |
_tJournal of bioenergetics and biomembranes _gvol. 31 _gno. 2 _gp. 153-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1023/a:1005455912711 _zAvailable from publisher's website |
| 999 |
_c10406950 _d10406950 |
||